Literature DB >> 3400595

Establishing airborne exposure control limits in the pharmaceutical industry.

E V Sargent1, G D Kirk.   

Abstract

In the course of employment, workers in the pharmaceutical industry are exposed to compounds which are designed to produce pharmacological effects. For the most part, exposure occurs in the handling of finely divided solids. Data from laboratory animal studies and clinical trials can be extrapolated to predict possible effects of exposure in the workplace. To that end a procedure for establishing workplace exposure control limits (ECLs) for pharmaceutical products is presented. Workplace exposure limits are given for 32 human health drugs.

Entities:  

Mesh:

Year:  1988        PMID: 3400595     DOI: 10.1080/15298668891379792

Source DB:  PubMed          Journal:  Am Ind Hyg Assoc J        ISSN: 0002-8894


  8 in total

Review 1.  Setting Occupational Exposure Limits for Genotoxic Substances in the Pharmaceutical Industry.

Authors:  Ester Lovsin Barle; Gian Christian Winkler; Susanne Glowienke; Azeddine Elhajouji; Jana Nunic; Hans-Joerg Martus
Journal:  Toxicol Sci       Date:  2016-05       Impact factor: 4.849

2.  Can Control Banding be Useful for the Safe Handling of Nanomaterials? A Systematic Review.

Authors:  Adrienne Eastlake; Ralph Zumwalde; Charles Geraci
Journal:  J Nanopart Res       Date:  2016-06-22       Impact factor: 2.253

3.  Control Banding Tools for Engineered Nanoparticles: What the Practitioner Needs to Know.

Authors:  Kevin H Dunn; Adrienne C Eastlake; Michael Story; Eileen D Kuempel
Journal:  Ann Work Expo Health       Date:  2018-02-23       Impact factor: 2.179

4.  Occupational safety and health criteria for responsible development of nanotechnology.

Authors:  P A Schulte; C L Geraci; V Murashov; E D Kuempel; R D Zumwalde; V Castranova; M D Hoover; L Hodson; K F Martinez
Journal:  J Nanopart Res       Date:  2013-12-07       Impact factor: 2.253

5.  The Scientific Basis of Uncertainty Factors Used in Setting Occupational Exposure Limits.

Authors:  D A Dankovic; B D Naumann; A Maier; M L Dourson; L S Levy
Journal:  J Occup Environ Hyg       Date:  2015       Impact factor: 2.155

6.  A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 Study.

Authors:  Etienne F Dumont; Amanda J Oliver; Chris Ioannou; Julia Billiard; Jeremy Dennison; Frans van den Berg; Shuying Yang; Vijayalakshmi Chandrasekaran; Graeme C Young; Anirban Lahiry; David C Starbuck; Andrew W Harrell; Alex Georgiou; Nathalie Hopchet; Andy Gillies; Stephen J Baker
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

7.  Review and Improvement of Chemical Hazard Risk Management of Korean Occupational Safety and Health Agency.

Authors:  Saemi Shin; Sang-Hoon Byeon
Journal:  Int J Environ Res Public Health       Date:  2021-09-06       Impact factor: 3.390

8.  Risk Assessment of Physical Hazards in Greek Hospitals Combining Staff's Perception, Experts' Evaluation and Objective Measurements.

Authors:  Styliani Gewrgios Tziaferi; Panayiota Sourtzi; Athina Kalokairinou; Evi Sgourou; Emmanouel Koumoulas; Emmanouel Velonakis
Journal:  Saf Health Work       Date:  2011-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.